Acamprosate Calcium Tablet, Delayed Release
Product Images NDC 68382-569

2 FDA label images from Zydus Pharmaceuticals (usa) Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Acamprosate Calcium (NDC 68382-569). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals (usa) Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

9435df69 F78d 4336 9f90 99fe4182340c 01

9435df69 F78d 4336 9f90 99fe4182340c 01
Chemical structure of acamprosate calcium showing its molecular components, including the calcium ion (Ca2+) and associated chemical groups.*
FDA Label Image

9435df69 F78d 4336 9f90 99fe4182340c 02

9435df69 F78d 4336 9f90 99fe4182340c 02
Label for Acamprosate Calcium delayed-release tablets, 333 mg, oral tablets. The label shows a white round tablet imprinted with '569'. The product is supplied as 180 tablets per container by Zydus Pharmaceuticals (USA) Inc. The label includes storage instructions and manufacturer details for Cadila Healthcare Ltd., India. The NDC is 68382-569-28.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.